NCT00551109View on ClinicalTrials.gov

SA4503 8-Week Study in Major Depressive Disorder (MDD)

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2007

Study Completion Date

September 30, 2008

Conditions
Depressive Disorder, Major
Interventions
DRUG

placebo

placebo, oral administration, once daily for 8 weeks

DRUG

SA4503 Low

Low dose, oral administration, once daily for 8 weeks

DRUG

SA4503 High

High dose, oral administration, once daily for 8 weeks

Trial Locations (5)

Unknown

Helsinki

Jyväskylä

Kuopio

Tampere

Turku

Sponsors
All Listed Sponsors
lead

M's Science Corporation

INDUSTRY